Edgewise Therapeutics, Inc.

Q2 2021 13F Holders

Symbol
EWTX
CUSIP
28036F105
Type
Equity
Class
COM
Num filings
47
Total reported value, excl. options
$1.03 B
Manager Report Date Value ($000) Shares Option Type